ISG15 is required for the dissemination of Vaccinia virus extracellular virions
M. Becares, M. Albert, C. Tarrega, R. Coloma, M. Falqui, E. Luhmann, L. Radoshevich, S. Guerra
Abstract
Viruses have developed many different strategies to counteract immune responses, and Vaccinia virus (VACV) is one of a kind in this aspect. To ensure an efficient infection, VACV undergoes a complex morphogenetic process resulting in the production of two types of infective virions: intracellular mature virus (MV) and extracellular enveloped virus (EV), whose spread depends on different dissemination mechanisms. MVs disseminate after cell lysis, whereas EVs are released or propelled in actin tails from living cells. Here we show that ISG15 participates in the control of VACV dissemination. Infection of Isg15-/- mouse embryonic fibroblasts with VACV International Health Department-J (IHD-J) strain resulted in decreased EV production, concomitant with reduced induction of actin tails and the abolition of comet-shaped plaque formation, comparing with Isg15+/+ cells. Transmission electron microscopy revealed accumulation of intracellular and a decrease in extracellular virus particles in the absence of Interferon Stimulated Gene 15 (ISG15), consistent with altered virus egress. Immunoblot and quantitative proteomic analysis of sucrose gradient-purified virions from both genotypes reported differences in protein levels and composition of viral proteins present on virions, suggesting an ISG15-mediated control of viral proteome. Last, the generation of a recombinant IHD-J expressing V5-tagged ISG15 (IHD-J-ISG15) allowed us to identify several viral proteins as potential ISG15 targets, highlighting the proteins A34 and A36, essential for EV formation. Altogether, our results indicate that ISG15 is an important host factor in the regulation of VACV dissemination. Author SummaryViral infections are a constant battle between the virus and the host. While the hosts only goal is victory, the main purpose of the virus is to spread and conquer new territories at the expense of the hosts resources. Along millions of years of incessant encounters, Poxviruses have developed a unique strategy consisting in the production two specialized "troops": intracellular mature virions (MVs) and extracellular virions (EVs). MVs mediate transmission between hosts, and EVs ensure advance on the battlefield mediating the long-range dissemination. The mechanism by which the virus decides to shed from the primary site of infection and its significant impact in viral transmission is not yet fully established. Here, we demonstrate that this process is finely regulated by ISG15/ISGylation, an interferon-induced ubiquitin-like protein with broad antiviral activity. Studying the mechanism that viruses use during infection could result in new ways of understanding our perpetual war against disease and how we might win the next great battle.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Vaccinia virus hijacks ESCRT-mediated multivesicular body formation for virus egress
M. Huttunen, A. Yakimovich, … J. Mercer·bioRxiv·Jul 15, 2020
- Extracellular ISG15 triggers ISGylation via a type-I interferon independent non-canonical mechanism to regulate host response during virus infection
Lindsay Grace Miller, Kim Lam Chiok, … Santanu Bose·bioRxiv·Jul 5, 2024
- Kinesin-1 transports morphologically distinct intracellular virions during vaccinia infection
A. Xu, A. Basant, … M. Way·Journal of Cell SciencePeer-reviewed·Mar 1, 2023
- Stability and characterization of infectious monkeypox virus extracellular virions in vitro2and vivo; implications for transmission, pathogenesis and treatment
K. Ostrowski, C. Davis, … Eric M. Mucker·bioRxiv·Mar 12, 2025
- Vaccinia E5 is a major inhibitor of the DNA sensor cGAS
- ISG15 drives immune pathology and respiratory failure during viral infection
N. Shaabani, J. Zak, … J. R. Teijaro·bioRxiv·Apr 13, 2020